Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease/Experiment 4

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-8-29

Curated date: 2024/08/20

Curator: Victoria

Revision editor(s): Victoria, WikiWorks, Tosin

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Nasal cavity Cavitas nasalis,Cavitas nasi,Cavity of nose,Cavity of olfactory apparatus,Cavum nasi,Nasal canal,Nasal conduit space,Nasal fossa,Nasal pit,Olfactory cavity,Olfactory chamber,Olfactory chamber cavity,Olfactory pit,Nasal cavity,nasal cavity
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Parkinson's disease IDIOPATHIC PARKINSON DIS,Idiopathic Parkinson Disease,Idiopathic Parkinson's Disease,IDIOPATHIC PARKINSONS DIS,Idiopathic PD,LEWY BODY PARKINSON DIS,Lewy Body Parkinson Disease,Lewy Body Parkinson's Disease,Paralysis agitans,paralysis agitans,PARKINSON DIS,PARKINSON DIS IDIOPATHIC,Parkinson disease,Parkinson Disease, Idiopathic,Parkinson syndrome,Parkinson's,Parkinson's disease,Parkinson's disease (disorder),Parkinson's disease NOS,Parkinson's disease NOS (disorder),Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinson's syndrome,Parkinsonian disorder,Parkinsonism, Primary,Parkinsons,PARKINSONS DIS,PARKINSONS DIS IDIOPATHIC,PARKINSONS DIS LEWY BODY,Parkinsons disease,Primary Parkinsonism,parkinson's disease
Group 0 name Corresponds to the control (unexposed) group for case-control studies
rHC (Random non-household healthy controls)
Group 1 name Corresponds to the case (exposed) group for case-control studies
SpHC (Spousal household healthy controls)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group consists of 11 spousal healthy controls of Parkinson's disease subjects.
Group 0 sample size Number of subjects in the control (unexposed) group
17
Group 1 sample size Number of subjects in the case (exposed) group
11
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
3 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
centered log-ratio
Statistical test
ANCOM
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Matched on Factors on which subjects have been matched on in a case-control study
age, race, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-8-29

Curated date: 2024/08/21

Curator: Victoria

Revision editor(s): Victoria, WikiWorks

Source: Supplementary table 6 & 7.

Description: Nasal microbial differences between rHC and SpHC subjects. Differential abundance differences were measured using ANCOM within SpHC (n=11) compared to rHC (n=17) subjects. At the genus and species taxonomic level.

Abundance in Group 1: increased abundance in SpHC (Spousal household healthy controls)

NCBI Quality ControlLinks
Acinetobacter guillouiae
Acinetobacter

Revision editor(s): Victoria, WikiWorks

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-8-29

Curated date: 2024/08/21

Curator: Victoria

Revision editor(s): Victoria, WikiWorks

Source: Supplementary table 6 & 7.

Description: Nasal microbial differences between rHC and SpHC subjects. Differential abundance differences were measured using ANCOM within SpHC (n=11) compared to rHC (n=17) subjects. At the genus and species taxonomic level.

Abundance in Group 1: decreased abundance in SpHC (Spousal household healthy controls)

NCBI Quality ControlLinks
Paraburkholderia xenovorans

Revision editor(s): Victoria, WikiWorks